Identification and Validation of a Novel Lactylation-related Gene Signature to Predict the Prognosis of Endometrial Cancer
In conclusion, our study demonstrated that the LRG signature is a promising biomarker for EC, effectively distinguishing high-risk patients, predicting prognosis, and offering new strategic directions for antitumor immunotherapy.
Authors
- Shuzhong Yao (ORCID: https://orcid.org/0000-0002-5145-5705)
- Meng Xia (ORCID: https://orcid.org/0000-0001-7657-1836)
- Xueyuan Zhao
- Chunyu Zhang (ORCID: https://orcid.org/0009-0001-5626-0528)
- Haolin Fan
- Hongye Jiang (ORCID: https://orcid.org/0000-0002-7550-2721)
- Weijia Wen (ORCID: https://orcid.org/0000-0003-3784-7494)
- Yuandong Liao
- Linna Chen
- Tianyu Liu (ORCID: https://orcid.org/0000-0002-1507-3793)
- Li Yuan (ORCID: https://orcid.org/0000-0002-0897-063X)
- Pan Liu (ORCID: https://orcid.org/0000-0002-6999-6550)
- Yan Jia (ORCID: https://orcid.org/0000-0002-0841-5097)
- Songlin Liu
- Wei Wang (ORCID: https://orcid.org/0000-0002-4431-6168)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Guangdong Provincial People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1007/s12672-025-02663-4
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- China Postdoctoral Science Foundation
- Medical Science and Technology Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Project
- Science and Technology Planning Project of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province